Ειδήσεις: BTIG | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

01/04 10:16 defenseworld.net

Bicara Therapeutics (NASDAQ:BCAX) Price Target Raised to $42.00 at HC Wainwright

Bicara Therapeutics price target HC Wainwright analyst ratings Citigroup Weiss Ratings

01/04 09:28 defenseworld.net

Xtant Medical (NYSEAMERICAN:XTNT) Price Target Cut to $1.00 by Analysts at BTIG Research

Xtant Medical BTIG Research price target buy rating medical device stock analysis

31/03 10:00 defenseworld.net

Opus Genetics (NASDAQ:IRD) Coverage Initiated by Analysts at Cantor Fitzgerald

Opus Genetics Cantor Fitzgerald Wedbush BTIG Weiss Ratings target price

30/03 14:10 yahoo.com

Upstart Holdings, Inc. (UPST) Rating Raised by BTIG as Bank Charter Could Reduce Funding Risk

Upstart BTIG rating upgrade bank charter funding risk fintech

30/03 12:40 defenseworld.net

Short Interest in Nomad Foods Limited (NYSE:NOMD) Declines By 17.0%

Nomad Foods short interest analyst rating BTIG Zacks stock forecast

30/03 11:16 defenseworld.net

Ascentage Pharma Group International – Unsponsored ADR (NASDAQ:AAPG) Receives Consensus Recommendation of “Buy” from Analysts

Ascentage Pharma AAPG analyst ratings buy recommendation price target Oppenheimer

29/03 23:44 yahoo.com

Why BTIG Cut Its Target on Humacyte (HUMA) but Kept a Bullish View on the Bigger Opportunity

BTIG Humacyte price target bullish vascular graft biotech

29/03 09:15 defenseworld.net

Humacyte (NASDAQ:HUMA) Earns Buy Rating from D. Boral Capital

Humacyte buy rating price objective D. Boral Capital UBS Group Benchmark

29/03 08:48 defenseworld.net

Needham & Company LLC Reiterates Buy Rating for Unity Software (NYSE:U)

Unity Software Needham Wedbush BTIG Oppenheimer buy rating

29/03 08:48 defenseworld.net

Needham & Company LLC Reiterates Buy Rating for Unity Software (NYSE:U)

Unity Software Needham Wedbush BTIG Oppenheimer buy rating

Loading...